Fidelity International’s VivoSim Labs VIVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,557
Closed -$982K 527
2017
Q2
$982K Hold
1,557
﹤0.01% 483
2017
Q1
$1.19M Hold
1,557
﹤0.01% 491
2016
Q4
$1.27M Hold
1,557
﹤0.01% 480
2016
Q3
$1.42M Hold
1,557
﹤0.01% 473
2016
Q2
$1.39M Hold
1,557
﹤0.01% 467
2016
Q1
$810K Hold
1,557
﹤0.01% 459
2015
Q4
$930K Hold
1,557
﹤0.01% 465
2015
Q3
$1M Buy
1,557
+1,128
+263% +$857K ﹤0.01% 479
2015
Q2
$388K Buy
+429
New +$480K ﹤0.01% 524

Other funds holding VIVS

Fidelity International's VIVS Position: Q3 2017 in Review

Fidelity International sold out of VivoSim Labs (VIVS) in Q3 2017, closing a stake of 1,557 shares — an estimated $982K sold.

Fidelity International first reported a position in VIVS in Q2 2015 and held it in 9 quarters. The position peaked at $1.42M in Q3 2016. 119 funds tracked by Wall St. Rank hold VIVS as of Q3 2017.

  • Fidelity International reported no remaining VivoSim Labs position as of Q3 2017 after selling out during the quarter.
  • Fidelity International sold 1,557 VivoSim Labs shares in Q3 2017, an estimated $982K.
  • Fidelity International first reported a position in VivoSim Labs in Q2 2015 and held it in 9 quarters.
  • Fidelity International's VivoSim Labs position peaked at $1.42M in Q3 2016.
  • 119 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2017.

Based on Fidelity International's 13F filing for Q3 2017, filed 13 Nov 2017.